Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
gene editing
Biotech
How Editas 'dragged' new CSO over after 37 years at Biogen
Linda Burkly, Ph.D., was 37 years into a career at Biogen when Editas CEO Gilmore O’Neill—himself an alum of big biotech—came knocking.
Annalee Armstrong
May 10, 2024 11:08am
US agencies outline new plan for biotech product regulation
May 9, 2024 4:00am
How Peter Marks plans to prevent '3 billion visits' to FDA
May 8, 2024 11:05am
Moderna exits Metagenomi gene editing deal worth $3B biobucks
May 1, 2024 4:00pm
Regeneron signs Mammoth gene editing deal worth $100M upfront
Apr 25, 2024 8:49am
Profluent combines LLMs, CRISPR for open-source AI gene editing
Apr 23, 2024 2:00pm